Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 8/20 | 0.60 |
| ▸ | CTSS | P25774 | 3/20 | 0.60 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7550254 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7839929 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL2706071 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL1926493 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7555645 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7550258 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7555646 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL7547359 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL5050858 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 | |
| SCHEMBL17356699 | 1.00 | CTSK (0.60) | CTSKCTSSNOD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713321-A1 | PROTACS FOR ASK1 PROTEIN DEGRADATION: PREPARATION AND USE THEREOF | Council of Scientific and Industrial Research (IN) | 2026-03-25 | — | — | EP | disclosed |
| US-20250090658-A1 | POLYMER ADJUVANT | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2025-03-20 | — | — | US | disclosed |
| WO-2024236595-A1 | PROTACS FOR ASK1 PROTEIN DEGRADATION: PREPARATION AND USE THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2024-11-21 | — | — | WO | disclosed |
| US-20210000934-A1 | POLYMER ADJUVANT | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2021-01-07 | — | — | US | disclosed |
| US-20170304420-A1 | POLYMER ADJUVANT | OXFORD UNIVERSITY INNOVATION LIMITED (GB) | 2017-10-26 | — | — | US | disclosed |
| EP-3215189-A1 | POLYMER ADJUVANT | Oxford University Innovation Limited (GB) | 2017-09-13 | — | — | EP | disclosed |
| WO-2016055812-A1 | POLYMER ADJUVANT | ISIS INNOVATION LIMITED (GB) | 2016-04-14 | — | — | WO | disclosed |
| CN-101092373-B | Method for synthesizing optically active derivative of 5 - aryl - (S) - N - boc - alpha amino pentanoic acid | YAOMINGKANGDE NEW MEDICINES CO LTD SHANGHAI | 2012-06-27 | — | — | CN | disclosed |
| CN-101092373-A | Method for synthesizing optically active derivative of 5 - aryl - (S) - N - boc - alpha amino pentanoic acid | YAOMINGKANGDE NEW MEDICINES CO (CN) | 2007-12-26 | — | — | CN | disclosed |
| WO-2004020402-A1 | SULPHONYLAMINO DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE | DE NOVO PHARMACEUTICALS LIMITED (GB) | 2004-03-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210000934-A1 | POLYMER ADJUVANT | TLR3, TLR9, TLR1 | CTSK 3543/4885CTSS 3284/4885NOD1 53/4885 |
| US-20170304420-A1 | POLYMER ADJUVANT | TLR3, TLR9, TLR1 | CTSK 3543/4885CTSS 3284/4885NOD1 53/4885 |
| US-20250090658-A1 | POLYMER ADJUVANT | TLR3, TLR9, TLR1 | CTSK 3543/4885CTSS 3284/4885NOD1 53/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.